{"id":28877,"date":"2026-05-28T11:30:45","date_gmt":"2026-05-28T17:30:45","guid":{"rendered":"https:\/\/canadianglycomics.ca\/?p=28877"},"modified":"2026-05-28T14:50:53","modified_gmt":"2026-05-28T20:50:53","slug":"glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round","status":"publish","type":"post","link":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/","title":{"rendered":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"28877\" class=\"elementor elementor-28877\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1d9b21b3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1d9b21b3\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-60ab717c\" data-id=\"60ab717c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-27093231 elementor-widget elementor-widget-spacer\" data-id=\"27093231\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9a31ce0 elementor-widget elementor-widget-page-title\" data-id=\"9a31ce0\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;align&quot;:&quot;center&quot;}\" data-widget_type=\"page-title.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\n\t\t<div class=\"hfe-page-title hfe-page-title-wrapper elementor-widget-heading\">\n\n\t\t\t\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">\n\t\t\t\t\t\t\t\t\n\t\t\t\tGlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round  \n\t\t\t<\/h1> \n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-516d26b9 elementor-widget elementor-widget-text-editor\" data-id=\"516d26b9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: center;\"><em>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/em><em>The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.<\/em><\/p><p style=\"text-align: center;\"><span style=\"color: #999999;\">Posted: May 28, 2026<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-29671345 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"29671345\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7c4c2844\" data-id=\"7c4c2844\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-197ae4d0 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"197ae4d0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2aa5432 elementor-widget elementor-widget-image\" data-id=\"2aa5432\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"300\" height=\"225\" src=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet-300x225.png\" class=\"attachment-medium size-medium wp-image-28879\" alt=\"\" srcset=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet-300x225.png 300w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet-1024x768.png 1024w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet-768x576.png 768w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet-16x12.png 16w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png 1200w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-56e2aed3 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"56e2aed3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>TORONTO \u2014 <a href=\"https:\/\/www.synakis.ca\/home\">Synakis<\/a> Corp., a Toronto-based biotechnology company developing ocular therapies for retinal disease and glaucoma, announced today the close of an oversubscribed CAD $2.6 million pre-seed financing round to advance <a href=\"https:\/\/www.synakis.ca\/what-we-do\">SNK-125<\/a>, its vitreous replacement therapy for retinal detachment.<\/p>\n<p>Proceeds will support completion of GLP toxicology studies by early 2027 for an Investigational Testing Authorization (ITA) filing with Health Canada, and lead optimization for ocular therapeutic delivery.<\/p>\n<p>The round was co-led by <a href=\"https:\/\/tiap.ca\/\">Toronto Innovation Acceleration Partners (TIAP)<\/a> and Chiefswood Private Capital Inc., with additional investment from the <a href=\"https:\/\/www.oc-innovation.ca\/\">Ontario Centre of Innovation (OCI)<\/a> through the <a href=\"https:\/\/www.oc-innovation.ca\/programs\/life-sciences-innovation-fund\/\">Life Sciences Innovation Fund (LSIF)<\/a>, and from the <a href=\"https:\/\/canadianglycomics.ca\/fr\/\">Canadian Glycomics Network (GlycoNet)<\/a> through the <a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/call-for-proposals\/\">Programme Kickstart<\/a>.<\/p>\n<p>Prakash Gowd, Interim President and CEO of TIAP, said, \u201cTIAP\u2019s investment reflects our mission of transforming Canadian health science innovation into successful commercial ventures and supporting high-potential startups.\u201d<\/p>\n<p>Jake Krembil, Vice-President of Chiefswood, added, \u201cAfter following Synakis for years, we remain impressed by the rigor of its science and platform.\u201d<\/p>\n<p>Synakis\u2019 proprietary carbohydrate-based hydrogel platform was designed for safe ocular delivery and enables vitreous replacement and sustained therapeutic delivery. SNK-125 is intended to eliminate blurry vision and face-down posturing associated with existing gas and oil treatments for retinal detachment. Independent validation reinforces the potential of Synakis\u2019 hydrogel in retinal therapeutics.<\/p>\n<p>Molly Shoichet, Synakis\u2019 CSO and Co-Founder, said, \u201cThe company is excited to advance technologies aimed at preserving vision.\u201d<\/p>\n<p>Dr. Rob Devenyi, vitreoretinal surgeon and Synakis\u2019 CMO and Co-Founder, noted \u201cthe need for improved patient solutions given the limitations of current retinal detachment treatments.\u201d<\/p>\n<p>Elizabeth Nanak, GlycoNet\u2019s CEO added, \u201cSynakis is advancing a promising approach to retinal repair that aligns closely with GlycoNet\u2019s mission to accelerate glycomics-enabled innovation toward new treatments. Through GlycoNet\u2019s Kickstart Program, we are proud to support companies advancing innovative biomaterials and technologies toward meaningful patient impact.\u201d<\/p>\n<p>Thierry Nivaggioli, Synakis\u2019 CEO, said, \u201cThis financing, together with independent validation, reinforces both the strength of our science and the unmet need for improved retinal therapies.\u201d<\/p>\n<p><strong>About Synakis<\/strong><\/p>\n<p>Synakis is a Toronto-based pre-clinical biotechnology company developing ocular products to preserve vision through its proprietary platform technology. The company is developing products for retinal diseases, retinal detachment, and glaucoma. Synakis was spun out of the laboratory of Professor Molly Shoichet at the University of Toronto. For more information, visit <a href=\"http:\/\/www.synakis.ca\">www.synakis.ca<\/a>.<\/p>\n<p><strong>About TIAP<\/strong><\/p>\n<p>TIAP supports commercialization of therapeutic, medical device, and digital health\/AI innovations from Toronto research institutions and has helped launch more than 70 companies that have raised over $1 billion in private investment.<\/p>\n<p><strong>About Chiefswood<\/strong><\/p>\n<p>Chiefswood Private Capital is a Canadian family office investment firm dedicated to supporting Canadian startups with patient, long-term capital.<\/p>\n<p><strong>\u00c0 propos de GlycoNet<\/strong><\/p>\n<p>GlycoNet is a pan-Canadian network advancing glycomics research, innovation, and commercialization in human and animal health, food security, and environmental sustainability. GlycoNet investigators use the study of carbohydrates (sugars) in living cells to find solutions to unmet health needs through the development of tools, drugs, vaccines and diagnostics. GlycoNet is supported in part through the Government of Canada\u2019s Strategic Science Fund, and the Canada Foundation for Innovation\u2019s Major Science Initiatives Fund.<\/p>\n<p>\u00a0<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>For more information, contact: info@synakis.ca<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9bf3619 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"9bf3619\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7590d33a elementor-widget elementor-widget-text-editor\" data-id=\"7590d33a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h6 style=\"text-align: center;\">Plus de <a href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/\">nouvelles de GlycoNet<\/a><\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-256dce24 elementor-widget elementor-widget-spacer\" data-id=\"256dce24\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6a86c32 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6a86c32\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0f43794\" data-id=\"0f43794\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.<\/p>","protected":false},"author":7,"featured_media":28879,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[204,3,200,203,4],"tags":[388,7,389,387,100],"class_list":["post-28877","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-community","category-news-releases","category-press-release","category-research-highlight","category-success-stories","tag-biotechnology","tag-glyconet","tag-ocular","tag-synakis","tag-therapeutics","wpbf-post"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Aalyssa A\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_CA\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Canadian Glycomics Network - Improving the quality of life of Canadians through glycomics\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network\" \/>\n\t\t<meta property=\"og:description\" content=\"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-28T17:30:45+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-28T20:50:53+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network\" \/>\n\t\t<meta name=\"twitter:description\" content=\"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#blogposting\",\"name\":\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network\",\"headline\":\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round\",\"author\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/aatley\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/wp-content\\\/uploads\\\/Synakis-GlycoNet.png\",\"width\":1200,\"height\":900},\"datePublished\":\"2026-05-28T11:30:45-06:00\",\"dateModified\":\"2026-05-28T14:50:53-06:00\",\"inLanguage\":\"fr-CA\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#webpage\"},\"articleSection\":\"Community, News Releases, Press Release, Research Highlight, Success Stories, Biotechnology, GlycoNet, ocular, Synakis, therapeutics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/#listItem\",\"name\":\"Network News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/#listItem\",\"position\":2,\"name\":\"Network News\",\"item\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/news-releases\\\/#listItem\",\"name\":\"News Releases\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/news-releases\\\/#listItem\",\"position\":3,\"name\":\"News Releases\",\"item\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/news-releases\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#listItem\",\"name\":\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/#listItem\",\"name\":\"Network News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#listItem\",\"position\":4,\"name\":\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/news-releases\\\/#listItem\",\"name\":\"News Releases\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Glycomics Network\",\"description\":\"Improving the quality of life of Canadians through glycomics\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/Glyconet-Logo-300x104.png\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#organizationLogo\",\"width\":300,\"height\":104},\"image\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/aatley\\\/#author\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/aatley\\\/\",\"name\":\"Aalyssa A\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3cf4cd1e6ab8a6862d8ec02acc5d0cb56b751db798bde47bced111792295425?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Aalyssa A\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#webpage\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/\",\"name\":\"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network\",\"description\":\"The CAD $2.6 million pre-seed financing round included support from GlycoNet\\u2019s Kickstart Program.\",\"inLanguage\":\"fr-CA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/aatley\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/aatley\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/wp-content\\\/uploads\\\/Synakis-GlycoNet.png\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#mainImage\",\"width\":1200,\"height\":900},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\\\/#mainImage\"},\"datePublished\":\"2026-05-28T11:30:45-06:00\",\"dateModified\":\"2026-05-28T14:50:53-06:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/\",\"name\":\"Canadian Glycomics Network\",\"description\":\"Improving the quality of life of Canadians through glycomics\",\"inLanguage\":\"fr-CA\",\"publisher\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network","description":"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.","canonical_url":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#blogposting","name":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network","headline":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round","author":{"@id":"https:\/\/canadianglycomics.ca\/fr\/author\/aatley\/#author"},"publisher":{"@id":"https:\/\/canadianglycomics.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png","width":1200,"height":900},"datePublished":"2026-05-28T11:30:45-06:00","dateModified":"2026-05-28T14:50:53-06:00","inLanguage":"fr-CA","mainEntityOfPage":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#webpage"},"isPartOf":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#webpage"},"articleSection":"Community, News Releases, Press Release, Research Highlight, Success Stories, Biotechnology, GlycoNet, ocular, Synakis, therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/#listItem","position":1,"name":"Home","item":"https:\/\/canadianglycomics.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/#listItem","name":"Network News"}},{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/#listItem","position":2,"name":"Network News","item":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/news-releases\/#listItem","name":"News Releases"},"previousItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/news-releases\/#listItem","position":3,"name":"News Releases","item":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/news-releases\/","nextItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#listItem","name":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round"},"previousItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/#listItem","name":"Network News"}},{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#listItem","position":4,"name":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round","previousItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/news-releases\/#listItem","name":"News Releases"}}]},{"@type":"Organization","@id":"https:\/\/canadianglycomics.ca\/fr\/#organization","name":"Canadian Glycomics Network","description":"Improving the quality of life of Canadians through glycomics","url":"https:\/\/canadianglycomics.ca\/fr\/","logo":{"@type":"ImageObject","url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/2019\/03\/Glyconet-Logo-300x104.png","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#organizationLogo","width":300,"height":104},"image":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/canadianglycomics.ca\/fr\/author\/aatley\/#author","url":"https:\/\/canadianglycomics.ca\/fr\/author\/aatley\/","name":"Aalyssa A","image":{"@type":"ImageObject","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/e3cf4cd1e6ab8a6862d8ec02acc5d0cb56b751db798bde47bced111792295425?s=96&d=mm&r=g","width":96,"height":96,"caption":"Aalyssa A"}},{"@type":"WebPage","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#webpage","url":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/","name":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network","description":"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.","inLanguage":"fr-CA","isPartOf":{"@id":"https:\/\/canadianglycomics.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#breadcrumblist"},"author":{"@id":"https:\/\/canadianglycomics.ca\/fr\/author\/aatley\/#author"},"creator":{"@id":"https:\/\/canadianglycomics.ca\/fr\/author\/aatley\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#mainImage","width":1200,"height":900},"primaryImageOfPage":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/#mainImage"},"datePublished":"2026-05-28T11:30:45-06:00","dateModified":"2026-05-28T14:50:53-06:00"},{"@type":"WebSite","@id":"https:\/\/canadianglycomics.ca\/fr\/#website","url":"https:\/\/canadianglycomics.ca\/fr\/","name":"Canadian Glycomics Network","description":"Improving the quality of life of Canadians through glycomics","inLanguage":"fr-CA","publisher":{"@id":"https:\/\/canadianglycomics.ca\/fr\/#organization"}}]},"og:locale":"fr_CA","og:site_name":"Canadian Glycomics Network - Improving the quality of life of Canadians through glycomics","og:type":"article","og:title":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network","og:description":"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.","og:url":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/","og:image":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png","og:image:secure_url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png","og:image:width":1200,"og:image:height":900,"article:published_time":"2026-05-28T17:30:45+00:00","article:modified_time":"2026-05-28T20:50:53+00:00","twitter:card":"summary_large_image","twitter:title":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round - Canadian Glycomics Network","twitter:description":"The CAD $2.6 million pre-seed financing round included support from GlycoNet\u2019s Kickstart Program.","twitter:image":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Synakis-GlycoNet.png"},"aioseo_meta_data":{"post_id":"28877","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-05-22 19:57:15","updated":"2026-09-10 15:49:46","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/\" title=\"Network News\">Network News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/news-releases\/\" title=\"News Releases\">News Releases<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tGlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/canadianglycomics.ca\/fr\/"},{"label":"Network News","link":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/"},{"label":"News Releases","link":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/news-releases\/"},{"label":"GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round","link":"https:\/\/canadianglycomics.ca\/fr\/glyconet-supported-startup-synakis-announces-close-of-oversubscribed-pre-seed-round\/"}],"_links":{"self":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts\/28877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/comments?post=28877"}],"version-history":[{"count":11,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts\/28877\/revisions"}],"predecessor-version":[{"id":28900,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts\/28877\/revisions\/28900"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/media\/28879"}],"wp:attachment":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/media?parent=28877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/categories?post=28877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/tags?post=28877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}